Jiangsu Bioperfectus Technologies Co., Ltd.

(SSE:688399)

BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution providers specialized in infectious diseases ever since 2010. With headquarter located in Jiangsu, subsidiaries in Shanghai, Beijing, Xi’an, Taizhou, Hainan and Yinchuan. Bioperfectus is pioneering in molecular diagnostics market with our products ranging from real time PCR kits, nucleic acid extraction systems, rapid tests and automation laboratory devices. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream to create a healthier future for our next generations.

62,000+㎡

An industrial park of over 62,000㎡ integrating fully self-innovative R&D, production, warehousing, logistics, sales, marketing and customer service divisions catering for various business scenarios

600+

Over 600 Bioperfectus people’s permission gathering the perseverance and determination to fight against the global pandemic

5,000,000+

Production capacity ramping up to more than 5 million tests/day ensuring the quick sufficient response to infectious diseases

global presence

80 Countries within a year

Bioperfectus Products & Service have been distributed to over 80+ countries around the globe within only one year since the international business established.

10000 Machinery spots

Bioperfectus Nucleic Acid Extraction Solutions
were launched in over 10,000 laboratories
globally with a well-trained and quick-response
customer service team.

Product Center

News Center

11-252021

We Salute All Health Frontiers: Happy Thanksgiving Day

11-252021

Roses are red, velvets are blue. What makes the world go bright, is the love, is the hope.On this special day, we would like to send our sincere gratitude to all the health frontiers, you are all heroes!

11-112021

New Member of COVID-19 Variant Detection Kit

11-112021

While the concern of the Delta variant infection has not faded away, our attentions were moved to the Lambda variant, which is now mainly widespread in South America. TheLambdavariant (C.37) was first identified in Peru in 2020 and according to the recent shared sequencing data, the strain has been detected in at least 37 countries. Peru, Chile, Argentina and even in the 46 states of America were reported with high cumulative prevalence rate ofLambdavariant. For now, theLambdavariant was design...

11-102021

Booster of Recovery from COVID-19: Bioperfectus Antigen Rapid Test

11-102021

With rapid promotion of immunization, many countries have entered into a new normal phase of COVID-19 recovery, more and more people started to realize that COVID-19 is a part of our daily life and it is going to be with us for quite a while. Under such circumstances, COVID-19 testing has become another effective tool for citizens to return back to normal life except vaccination. Among all the testing technology, lateral flow method allows the testing to be faster, easier and cheaper. Wi...

Learn More

Service Network

Support is only one step away

A good after-sales service is essential for efficiency of workload in PCR laboratory. Bioperfectus delivers most perfect service via our authorized distributors and global service center. With well-experienced service staff, sufficient spare-part inventory and fast global logistics, Bioperfectus aims to provide with the satisfactory solutions to our end users.We offer 24/7 after-sales service, prompt response and periodical training programs.

CONTACT US NOW